Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
15.09 (1y: +30%)
Market Cap 245.7 M P/E(ttm) 24.30
Enterprise Value 232.75 M P/B 3.24
VASC- NAS (USA)
Vascular Solutions, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$15.09
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry		 vs
history
Cash to Debt No Debt
VASC's Cash to Debt is ranked lower than
628930% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.63 vs. VASC: No Debt )
VASC' s 10-Year Cash to Debt Range
Min: 1.53   Max: No Debt
Current: No Debt
Equity to Asset 0.615
VASC's Equity to Asset is ranked lower than
699300% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.56 vs. VASC: 0.615 )
VASC' s 10-Year Equity to Asset Range
Min: 0.4   Max: 0.95
Current: 0.62
0.4
0.95
Interest Coverage 1223.5
VASC's Interest Coverage is ranked lower than
877192% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 73.90 vs. VASC: 1223.5 )
VASC' s 10-Year Interest Coverage Range
Min: 1224   Max: No Debt
Current: 1223.5
F-Score: 5
Z-Score: 14.25
M-Score: -2.98
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry		 vs
history
Operating margin (%) 16.20
VASC's Operating margin (%) is ranked lower than
892856% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.00 vs. VASC: 16.20 )
VASC' s 10-Year Operating margin (%) Range
Min: -576.2   Max: 17.3
Current: 16.2
-576.2
17.3
Net-margin (%) 10.1
VASC's Net-margin (%) is ranked lower than
980391% of the 102 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.20 vs. VASC: 10.1 )
VASC' s 10-Year Net-margin (%) Range
Min: -550.2   Max: 27.3
Current: 10.1
-550.2
27.3
ROE (%) 12.9
VASC's ROE (%) is ranked lower than
990098% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.30 vs. VASC: 12.9 )
VASC' s 10-Year ROE (%) Range
Min: -88.6   Max: 50.8
Current: 12.9
-88.6
50.8
ROA (%) 11.3
VASC's ROA (%) is ranked lower than
980391% of the 102 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.30 vs. VASC: 11.3 )
VASC' s 10-Year ROA (%) Range
Min: -74.1   Max: 36.6
Current: 11.3
-74.1
36.6
ROC (Joel Greenblatt) (%) 38.60
VASC's ROC (Joel Greenblatt) (%) is ranked lower than
900900% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.40 vs. VASC: 38.60 )
VASC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1280.6   Max: 51
Current: 38.6
-1280.6
51
Revenue Growth (%) 9.6
VASC's Revenue Growth (%) is ranked lower than
1176469% of the 85 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.60 vs. VASC: 9.6 )
VASC' s 10-Year Revenue Growth (%) Range
Min: 6.3   Max: 33.2
Current: 9.6
6.3
33.2
EBITDA Growth (%) 19.4
VASC's EBITDA Growth (%) is ranked lower than
1587300% of the 63 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.70 vs. VASC: 19.4 )
VASC' s 10-Year EBITDA Growth (%) Range
Min: -51.3   Max: 130
Current: 19.4
-51.3
130
EPS Growth (%) 16.1
VASC's EPS Growth (%) is ranked lower than
1923075% of the 52 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.30 vs. VASC: 16.1 )
VASC' s 10-Year EPS Growth (%) Range
Min: -56.6   Max: 16.1
Current: 16.1
-56.6
16.1
ยป VASC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

VASC Guru Trades in Q2 2012

Jim Simons 37,700 sh (+236.61%)
Mario Gabelli 325,696 sh (-4.46%)
» More
Q3 2012

VASC Guru Trades in Q3 2012

Mario Gabelli 326,696 sh (+0.31%)
Jim Simons Sold Out
» More
Q4 2012

VASC Guru Trades in Q4 2012

Joel Greenblatt 10,137 sh (New)
Mario Gabelli 320,471 sh (-1.91%)
» More
Q1 2013

VASC Guru Trades in Q1 2013

Jim Simons 145,300 sh (New)
Bill Frels 82,300 sh (New)
Joel Greenblatt Sold Out
Mario Gabelli 317,871 sh (-0.81%)
» More
» Details

Insider Trades

Latest Guru Trades with VASC

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-03-31 Sold Out 0.01%$14.4 - $16.71 $ 15.09-3%0
Joel Greenblatt 2012-12-31 New Buy0.01%$13.32 - $15.35 $ 15.093%10137
Mario Gabelli 2011-03-31 Reduce -32.85%0.01%$10.48 - $12.06 $ 15.0937%397196
Mario Gabelli 2010-09-30 Add 41.04%0.01%$10.93 - $12.64 $ 15.0928%600796
Mario Gabelli 2010-06-30 Reduce -32.34%0.01%$9.05 - $13.04 $ 15.0941%425971
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 24.20
VASC's P/E(ttm) is ranked lower than
934579% of the 107 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.90 vs. VASC: 24.20 )
VASC' s 10-Year P/E(ttm) Range
Min: 5.09   Max: 447.5
Current: 24.2
5.09
447.5
P/B 3.20
VASC's P/B is ranked lower than
657894% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.50 vs. VASC: 3.20 )
VASC' s 10-Year P/B Range
Min: 0.38   Max: 16.9
Current: 3.2
0.38
16.9
P/S 2.48
VASC's P/S is ranked lower than
628930% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. VASC: 2.48 )
VASC' s 10-Year P/S Range
Min: 0.82   Max: 33.21
Current: 2.48
0.82
33.21
PFCF 27.50
VASC's PFCF is ranked lower than
1063829% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.70 vs. VASC: 27.50 )
VASC' s 10-Year PFCF Range
Min: 10.72   Max: 50.14
Current: 27.5
10.72
50.14
EV-to-EBIT 15.9
VASC's EV-to-EBIT is ranked lower than
704225% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.73 vs. VASC: 15.9 )
VASC' s 10-Year EV-to-EBIT Range
Min: 9.7   Max: 387
Current: 15.9
9.7
387
PEG 0.6
VASC's PEG is ranked lower than
1694914% of the 59 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. VASC: 0.6 )
VASC' s 10-Year PEG Range
Min: 0.42   Max: 0.6
Current: 0.6
0.42
0.6
Shiller P/E 20.4
VASC's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: vs. VASC: 20.4 )
VASC' s 10-Year Shiller P/E Range
Min: 18.8   Max: 149.17
Current: 20.4
18.8
149.17

Valuation & Return

vs
industry		 vs
history
Price/Net Cash 503
VASC's Price/Net Cash is ranked lower than
1999998% of the 50 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.90 vs. VASC: 503 )
VASC' s 10-Year Price/Net Cash Range
Min: 0.9   Max: 526.7
Current: 503
0.9
526.7
Price/Net Current Asset Value 14.4
VASC's Price/Net Current Asset Value is ranked lower than
684931% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.00 vs. VASC: 14.4 )
VASC' s 10-Year Price/Net Current Asset Value Range
Min: 4.2   Max: 29.5
Current: 14.4
4.2
29.5
Price/Tangible Book 4.6
VASC's Price/Tangible Book is ranked lower than
704225% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.60 vs. VASC: 4.6 )
VASC' s 10-Year Price/Tangible Book Range
Min: 0.7   Max: 10.5
Current: 4.6
0.7
10.5
Price/DCF (Projected) 1.7
VASC's Price/DCF (Projected) is ranked lower than
1538460% of the 65 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.50 vs. VASC: 1.7 )
VASC' s 10-Year Price/DCF (Projected) Range
Min: 1.6   Max: 4.5
Current: 1.7
1.6
4.5
Price/Median PS Value 0.9
VASC's Price/Median PS Value is ranked lower than
649350% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. VASC: 0.9 )
VASC' s 10-Year Price/Median PS Value Range
Min: 0.4   Max: 4.3
Current: 0.9
0.4
4.3
Price/Peter Lynch Fair Value 1
VASC's Price/Peter Lynch Fair Value is ranked lower than
3124997% of the 32 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. VASC: 1 )
VASC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.3   Max: 1.6
Current: 1
0.3
1.6
Price/Graham Number 2.3
VASC's Price/Graham Number is ranked lower than
1041666% of the 96 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. VASC: 2.3 )
VASC' s 10-Year Price/Graham Number Range
Min: 1.3   Max: 2.4
Current: 2.3
1.3
2.4
Earnings Yield (Greenblatt) 6.30
VASC's Earnings Yield (Greenblatt) is ranked lower than
799999% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. VASC: 6.30 )
VASC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.3   Max: 10.3
Current: 6.3
0.3
10.3
Forward Rate of Return (Yacktman) 49.65
VASC's Forward Rate of Return (Yacktman) is ranked lower than
1960782% of the 51 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.37 vs. VASC: 49.65 )
VASC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -7   Max: 56.3
Current: 49.65
-7
56.3

Business Description

Vascular Solutions, Inc. was incorporated in the state of Minnesota in December 1996, and began operations in February 1997. It is a medical device Company focused on bringing clinically advanced solutions to interventional cardiologists and interventional radiologists worldwide. As a vertically-integrated medical device company, it generates ideas, create new minimally invasive medical devices, and then deliver these products and related services to physicians through its direct domestic sales force and its international distribution network. Its products and services are divided into three categories: Catheter products, principally consisting of catheters used in minimally invasive medical procedures for the diagnosis or treatment of vascular conditions, such as the Pronto extraction catheters used in treating acute myocardial infarction, and also including products used in connection with gaining percutaneous access to the vasculature to perform minimally invasive procedures, such as micro-introducer kits; Hemostat (blood clotting) products, principally consisting of the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat Flowable, a thick yet flowable thrombin-based mixture for preventing bleeding in subcutaneous pockets; and Vein products and services, principally consisting of the Vari-Lase endovenous laser, a laser console and procedure kit used for the treatment of varicose veins. The Company manufactures its products in its facilities located in the suburbs of Minneapolis, Minnesota and in the country of Ireland. The catheter manufacturing and packaging processes occur under a controlled clean room environment. It purchases components from various suppliers and rely on single sources for several parts of its products. It purchases its requirements for thrombin for use in manufacturing products sold in the U.S. under the Thrombin-JMI Supply Agreement with King. Its main competitors include: Medtronic, Abbott Laboratories, Johnson & Johnson, Boston Scientific, Covidien, Merit Medical, Marine Polymer Technologies, Hemcon Medical Technologies, Cook Medical, MedRad, Spectranetics, AngioDynamics, biolitec, Dornier MedTech, St. Jude Medical and Terumo. The Company's products and services are regulated in the United States as medical devices by the FDA under the Federal Food, Drug and Cosmetic Act.
Company Website
SEC Reports
Industry: Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO
Traded in other countries:VA4.Germany
ยป More Articles for VASC

Headlines

Articles On GuruFocus.com
Vascular Solutions Inc. Reports Operating Results (10-K) Feb 01 2011 
Vascular Solutions Inc. (VASC) CEO Howard Root sells 25,000 Shares Nov 04 2010 
Vascular Solutions Inc. Reports Operating Results (10-K) Feb 02 2010 
Vascular Solutions Inc. Reports Operating Results (10-Q) Apr 17 2009 

More From Our Partners
BSX Entangled in Patent Issues - Analyst Blog May 22 2013 - ZACKS

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial